{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:34:49Z","timestamp":1777883689844,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bmcl.2026.130597","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:20:47Z","timestamp":1771978847000},"page":"130597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["4-Aryl-2-aminoimidazole analogues of bromoageliferin with antimicrobial activity against Acinetobacter baumannii show in vitro inhibition of translocase MraY on the peptidoglycan biosynthesis pathway"],"prefix":"10.1016","volume":"136","author":[{"given":"Roisin","family":"Murphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia A.","family":"Fairbairn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Becca W.A.","family":"Baileeves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip J.","family":"Stansfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy D.H.","family":"Bugg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2026.130597_bb0005","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","article-title":"ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics","volume":"22","author":"Miller","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmcl.2026.130597_bb0010","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/nbt1266","article-title":"New antibiotics from bacterial natural products","volume":"24","author":"Clardy","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.bmcl.2026.130597_bb0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1574-6976.2007.00089.x","article-title":"The biosynthesis of peptidoglycan lipid-linked intermediates","volume":"32","author":"Bouhss","year":"2008","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.bmcl.2026.130597_bb0020","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.2174\/0929867325666180330095154","article-title":"Bacterial transferase MraY, a source of inspiration towards new antibiotics","volume":"25","author":"Fer","year":"2018","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmcl.2026.130597_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118234","article-title":"MraY: an emerging therapeutic target in bacterial peptidoglycan biosynthesis for the discovery of novel antibiotics from natural and synthetic origin","volume":"301","author":"Dash","year":"2026","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130597_bb0030","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1126\/science.1236501","article-title":"Crystal structure of MraY, an essential membrane enzyme for bacterial cell wall synthesis","volume":"341","author":"Chung","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2026.130597_bb0035","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1016\/j.jmb.2020.03.017","article-title":"Structures of bacterial MraY and human GPT provide insights into rational antibiotic design","volume":"432","author":"Mashalidis","year":"2020","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmcl.2026.130597_bb0040","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.1074\/jbc.271.13.7609","article-title":"Slow-binding inhibition of phospho-MurNAc-pentapeptide translocase (Escherichia coli) by mureidomycin a","volume":"271","author":"Brandish","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2026.130597_bb0045","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1128\/AAC.40.7.1640","article-title":"Modes of action of tunicamycin, liposidomycin B and mureidomycin a: inhibition of phospho-MurNAc-pentapeptide translocase from Escherichia coli","volume":"40","author":"Brandish","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2026.130597_bb0050","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1021\/ja003292c","article-title":"Stereochemical elucidation and total synthesis of dihydropacidamycin D, a semisynthetic pacidamycin","volume":"123","author":"Boojamra","year":"2001","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2026.130597_bb0055","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1016\/S0960-894X(03)00682-6","article-title":"Synthetic dihydropacidamycin antibiotics: a modified spectrum of activity for the pacidamycin class","volume":"13","author":"Boojamra","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2026.130597_bb0060","doi-asserted-by":"crossref","first-page":"15292","DOI":"10.1002\/chem.201404775","article-title":"Lead structures for new antibacterials: stereocontrolled synthesis of a bioactive muraymycin analogue","volume":"20","author":"Spork","year":"2014","journal-title":"Chem Eur J"},{"key":"10.1016\/j.bmcl.2026.130597_bb0065","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature17636","article-title":"Structural insights into inhibition of lipid I production in bacterial cell wall synthesis","volume":"533","author":"Chung","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2026.130597_bb0070","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41429-019-0227-3","article-title":"Mechanism of action of nucleoside antibacterial natural products","volume":"72","author":"Bugg","year":"2019","journal-title":"J Antibiotics"},{"key":"10.1016\/j.bmcl.2026.130597_bb0075","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1073\/pnas.97.8.4297","article-title":"Genetic evidence that the bacteriophage \u03d5X174 lysis protein inhibits cell wall synthesis","volume":"97","author":"Bernhardt","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2026.130597_bb0080","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1074\/jbc.M007638200","article-title":"The lysis protein E of \u03d5X174 is a specific inhibitor of the MraY-catalyzed step in peptidoglycan synthesis","volume":"276","author":"Bernhardt","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2026.130597_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/science.adg9091","article-title":"The mechanism of the phage-encoded protein antibiotic from \u03c6X174","volume":"381","author":"Orta","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2026.130597_bb0090","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/cbic.201402064","article-title":"Identification of a novel inhibition site in translocase MraY based upon the site of interaction with lysis protein E from bacteriophage \u03c6X174","volume":"15","author":"Rodolis","year":"2014","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bmcl.2026.130597_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116502","article-title":"Peptidomimetic analogues of Arg-Trp-x-x-Trp motif targeting interaction site of translocase MraY with bacteriophage \u03c6X174 lysis protein E","volume":"52","author":"Kerr","year":"2021","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2026.130597_bb0100","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1039\/D4MD00937A","article-title":"Antimicrobial triazinedione inhibitors of the translocase MraY\u2013protein E interaction site: synergistic effects with bacitracin imply a new mechanism of action","volume":"16","author":"Fairbairn","year":"2025","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmcl.2026.130597_bb0105","doi-asserted-by":"crossref","first-page":"13023","DOI":"10.1039\/C4CC06516F","article-title":"Mechanism of action of the uridyl peptide antibiotics: an unexpected link to a protein-protein interaction site in translocase MraY","volume":"50","author":"Rodolis","year":"2014","journal-title":"Chem Commun"},{"key":"10.1016\/j.bmcl.2026.130597_bb0110","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2174\/1389557511313130007","article-title":"2-aminoimidazoles in medicinal chemistry","volume":"13","author":"Zula","year":"2013","journal-title":"Mini-Rev Med Chem"},{"key":"10.1016\/j.bmcl.2026.130597_bb0115","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1021\/jo00009a008","article-title":"Bioactive bromopyrrole metabolites from the caribbean sponge Agelas conifera","volume":"56","author":"Keifer","year":"1991","journal-title":"J Organomet Chem"},{"key":"10.1016\/j.bmcl.2026.130597_bb0120","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/md18060326","article-title":"In vitro and in vivo assessment of the efficacy of bromoageliferin, an alkaloid isolated from the sponge Agelas dilatata, against Pseudomonas aeruginosa","volume":"18","author":"Pech-Puch","year":"2020","journal-title":"Marine Drugs"},{"key":"10.1016\/j.bmcl.2026.130597_bb0125","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1021\/acs.jnatprod.2c00094","article-title":"Feature-based molecular networking discovery of bromopyrrole alkaloids from the marine sponge Agelas dispar","volume":"85","author":"Freire","year":"2022","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmcl.2026.130597_bb0130","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.1021\/ja069017t","article-title":"Inhibition of Pseudomonas aeruginosa biofilm formation with bromoageliferin analogues","volume":"129","author":"Huigens","year":"2007","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2026.130597_bb0135","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1039\/b719082d","article-title":"Inhibition and dispersion of Pseudomonas aeruginosa biofilms with reverse amide 2-aminoimidazole oroidin analogues","volume":"6","author":"Richards","year":"2008","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmcl.2026.130597_bb0140","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/cmdc.201900033","article-title":"Identification of anti-mycobacterial biofilm agents based on the 2-aminoimidazole scaffold","volume":"14","author":"Nguyen","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmcl.2026.130597_bb0145","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1021\/acs.biochem.2c00560","article-title":"2-aminoimidazole analogs target PhoP altering DNA binding activity and affect outer membrane stability in gram-negative bacteria","volume":"61","author":"Zeczycki","year":"2022","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmcl.2026.130597_bb0150","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1021\/ol034806q","article-title":"Ruthenium porphyrin catalyzed intramolecular carbenoid C-H insertion. Stereoselective synthesis of cis-disubstituted oxygen and nitrogen heterocycles","volume":"5","author":"Cheung","year":"2003","journal-title":"Org Lett"},{"key":"10.1016\/j.bmcl.2026.130597_bb0155","doi-asserted-by":"crossref","first-page":"7299","DOI":"10.1021\/jo00103a021","article-title":"A simple and practical synthesis of 2-aminoimidazoles","volume":"59","author":"Little","year":"1994","journal-title":"J Organomet Chem"},{"key":"10.1016\/j.bmcl.2026.130597_bb0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmcl.2026.130597_bb0165","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1016\/j.bmc.2014.07.035","article-title":"Identification of novel inhibitors of translocase MraY from library screening: isoquinoline alkaloid michellamine B and xanthene dye phloxine B","volume":"22","author":"Mihalyi","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2026.130597_bb0170","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02240-21","article-title":"Elucidating the mechanisms of action of antimicrobial agents","volume":"13","author":"Hudson","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.bmcl.2026.130597_bb0175","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1128\/JB.180.23.6429-6432.1998","article-title":"mraY is an essential gene for cell growth in Escherichia coli","volume":"180","author":"Boyle","year":"1998","journal-title":"J Bacteriol"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26000648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26000648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:54:46Z","timestamp":1777600486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26000648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":35,"alternative-id":["S0960894X26000648"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130597","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"4-Aryl-2-aminoimidazole analogues of bromoageliferin with antimicrobial activity against Acinetobacter baumannii show in vitro inhibition of translocase MraY on the peptidoglycan biosynthesis pathway","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"130597"}}